Current treatments for dry eye disease do not work for everyone. A preliminary investigation of new antibody based eye drops produces encouraging results.
Tag: dry eye
Xiidra (lifitegrast)
Xiidra (lifitegrast) is a brand-name prescription drug that’s used to treat dry eye disease. Xiidra comes as liquid eye drops that are used twice daily. It’s approved for use in people ages 17 years and older. Learn about side effects, dosage, uses, an…
What role do immune cells play in dry eye?
Dry eye and inflammation that arise from disruption of moisturizing oil glands in the eyelids could be due to blockage by immune cells, a new study finds.
July is Dry Eye Awareness Month
July has been Dry Eye Awareness month. This is the first of several articles to raise awareness of dry eye.
The post July is Dry Eye Awareness Month appeared first on Retina Specialist | Fairfax, Virginia | Retinal Diseases.
What to know about punctal plugs for dry eye
Punctal plugs are small medical devices that doctors can insert into the tear ducts in a procedure called punctal occlusion. The plugs may be temporary or last many years, and they keep the eyes lubricated to improve dry eye symptoms. Here, learn about…
Do You Have Dry Eye?
Did you know that tearing is actually a common symptom of dry eye? Here’s a review of the symptoms and causes of dry eye.
The post Do You Have Dry Eye? appeared first on Retina Specialist | Fairfax, Virginia | Retinal Diseases.
Denali Concrete Management Inc. Announces The Commencement Of Patient Enrollment For The Phase 3 Dry Eye Syndrome Study
Denali Concrete Management Inc. (OTCBB: DCMG) announced that it has commenced patient enrollment for a phase 3 clinical study of the safety and efficacy of CF101, daily administered orally, in patients with moderate-to-severe Dry Eye Syndrome. This mul…
Status of Strategic Partnership Discussions Related to RGN-259 Ophthalmic Eye Drop
ROCKVILLE, Md.–(BUSINESS WIRE)–RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) is updating stockholders on the status of strategic discussions related to its ophthalmic drug candidate, RGN-259. Since…
New Dry Eye Treatments in the Pipeline
OSN: Several promising treatments are in the pipeline for dry eye, which is an “epidemic” and can drive patients to drink. Secretagogues stimulate the eye to produce its own tears, like Restasis. One is called Lancovutide which was originally used in cystic fibrosis. Rebamipide’s mechanism is to increase the mucin level in tears, which makes […]
Don’t Use the Term “Dry Eye”- Use Dysfunctional Tear Syndrome
“Dry eye” is a misnomer. It confuses patients- how can their eyes be dry, when the most common symptom is tearing?! Better to use the term “dysfunctional tear syndrome”. The tears work properly when all three components (the aqueous, mucin and oily layers) are present in their correct proportions. If not, then even though you […]
Mimetogen Pharmaceuticals Announces Initiation Of Phase II Clinical Trial Of Novel NGF Mimetic In Patients With Dry Eye
Mimetogen Pharmaceuticals Inc., a clinical-stage biotechnology company focused on developing novel small molecule compounds that mimic the effects of neurotrophins, today announced that it has initiated the first human clinical trial evaluating MIM-D…
Celtic Therapeutics And Resolvyx Pharmaceuticals Announce An Alliance In Ophthalmology
Celtic Therapeutics Holdings L.P. (Celtic Therapeutics), a successor firm to Celtic Pharma, and Resolvyx Pharmaceuticals, Inc. (Resolvyx) announced that they have entered into an option agreement relating to Resolvyx’s RX-10045, a late-stage program fo…